tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Teva Pharmaceutical Industries Ltd

TEVA
Add to Watchlist
35.000USD
-0.410-1.16%
Close 07-31 16:00（ET）Quotes delayed by 15 min
40.77BMarket Cap
28.42P/E TTM

Teva Pharmaceutical Industries Ltd

35.000
-0.410-1.16%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

TEVA Financials

See Teva Pharmaceutical Industries Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Teva Pharmaceutical Industries Ltd Earnings Date

Latest Release
Jul 29, 2026
EPS / Forecast
-0.49/0.27
Revenue / Forecast
4.15B/4.02B
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
17.32B
4.92%
EPS(YoY)
1.23
184.98%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-301.10%-0.49
69.74%0.32
318.50%0.42
197.88%0.38
132.93%0.25
251.92%0.19
-149.91%-0.19
-726.65%-0.39
4.09%-0.75
37.27%-0.12
132.47%0.38
--0.06
---0.78
---0.20
---1.18
---1.02
----
----
----
----
Revenue
-0.62%4.15B
2.06%3.97B
11.73%4.72B
3.42%4.48B
0.29%4.18B
1.89%3.89B
-5.58%4.23B
12.52%4.33B
7.37%4.16B
4.32%3.82B
13.62%4.48B
8.12%3.85B
2.89%3.88B
0.52%3.66B
-3.81%3.94B
-8.01%3.56B
-3.97%3.77B
-7.89%3.64B
-8.40%4.10B
-2.49%3.87B
Net Profit
-304.26%-576.00M
72.43%369.00M
321.20%480.00M
199.08%433.00M
133.33%282.00M
253.96%214.00M
-150.58%-217.00M
-733.33%-437.00M
2.98%-846.00M
36.82%-139.00M
132.65%429.00M
23.21%69.00M
-275.86%-872.00M
76.96%-220.00M
-726.42%-1.31B
-80.82%56.00M
-212.08%-232.00M
-1340.26%-955.00M
-206.00%-159.00M
106.71%292.00M
Net Margin
-304.45%-13.86%
64.35%9.29%
256.55%10.18%
207.61%9.69%
132.29%6.78%
151.53%5.65%
-167.26%-6.50%
-550.14%-9.00%
10.16%-20.99%
-58.76%-10.97%
128.31%9.67%
--2.00%
---23.36%
---6.91%
---34.15%
---10.51%
----
----
----
----
Gross Margin
1.14%52.29%
0.29%49.36%
10.22%56.74%
3.58%52.70%
3.20%51.70%
5.36%49.22%
-8.14%51.48%
2.66%50.88%
1.13%50.10%
8.31%46.71%
2.37%56.04%
--49.56%
--49.54%
--43.13%
--54.74%
--48.02%
----
----
----
----
Debt to assets ratio
-3.02%41.63%
-4.20%41.53%
-8.79%41.25%
-7.32%42.13%
-4.81%42.93%
-5.62%43.35%
-0.87%45.22%
-4.23%45.45%
-6.02%45.09%
-3.54%45.93%
-5.36%45.62%
--47.46%
--47.98%
--47.61%
--48.20%
--48.06%
----
----
----
----
Income Statement
Revenue
-0.62%4.15B
2.06%3.97B
11.73%4.72B
3.42%4.48B
0.29%4.18B
1.89%3.89B
-5.58%4.23B
12.52%4.33B
7.37%4.16B
4.32%3.82B
13.62%4.48B
8.12%3.85B
2.89%3.88B
0.52%3.66B
-3.81%3.94B
-8.01%3.56B
-3.97%3.77B
-7.89%3.64B
-8.40%4.10B
-2.49%3.87B
Operating profit
-75.32%235.00M
-1.78%772.00M
37.38%1.31B
6.43%1.13B
8.06%952.00M
20.18%786.00M
-31.15%955.00M
29.18%1.06B
9.58%881.00M
29.50%654.00M
28.07%1.39B
16.01%819.00M
12.13%804.00M
-34.33%505.00M
11.76%1.08B
-10.63%706.00M
-15.05%717.00M
0.39%769.00M
20.97%969.00M
8.37%790.00M
Net Profit
-304.26%-576.00M
72.43%369.00M
321.20%480.00M
199.08%433.00M
133.33%282.00M
253.96%214.00M
-150.58%-217.00M
-733.33%-437.00M
2.98%-846.00M
36.82%-139.00M
132.65%429.00M
23.21%69.00M
-275.86%-872.00M
76.96%-220.00M
-726.42%-1.31B
-80.82%56.00M
-212.08%-232.00M
-1340.26%-955.00M
-206.00%-159.00M
106.71%292.00M
Balance Sheet
Current assets
9.03%13.76B
18.93%13.71B
11.11%13.95B
3.43%12.74B
8.49%12.62B
-6.25%11.53B
0.54%12.55B
7.78%12.31B
-3.77%11.63B
6.92%12.30B
3.60%12.48B
-0.24%11.43B
-0.62%12.09B
-7.63%11.50B
-4.15%12.05B
-5.77%11.45B
-5.13%12.16B
0.40%12.45B
-3.32%12.57B
-0.05%12.15B
Total current liabilities
31.91%15.65B
21.29%13.53B
5.16%13.46B
-16.71%11.49B
-9.02%11.86B
-19.11%11.16B
4.48%12.80B
21.09%13.80B
10.08%13.04B
32.48%13.79B
6.78%12.25B
-1.21%11.39B
7.70%11.84B
-10.35%10.41B
4.01%11.47B
-2.46%11.53B
-13.36%11.00B
-3.94%11.61B
-16.23%11.03B
-2.30%11.82B
Total assets
-0.68%39.86B
4.23%40.04B
3.62%40.75B
-4.55%39.86B
-2.92%40.13B
-10.19%38.41B
-9.55%39.33B
-0.78%41.76B
-4.08%41.34B
-1.57%42.77B
-1.21%43.48B
-4.89%42.09B
-6.18%43.09B
-7.66%43.46B
-7.67%44.01B
-7.52%44.25B
-6.63%45.93B
-3.97%47.06B
-5.87%47.67B
-3.79%47.85B
Total liabilities
-3.59%32.10B
-1.05%31.81B
-3.28%32.83B
-7.84%32.60B
-4.25%33.30B
-8.75%32.15B
-3.98%33.95B
2.31%35.38B
-1.73%34.77B
1.11%35.23B
-0.17%35.35B
-0.45%34.58B
-1.99%35.39B
-5.31%34.84B
-2.77%35.41B
-4.58%34.73B
-4.70%36.10B
-3.23%36.80B
-7.98%36.42B
-7.01%36.40B
Total equity
13.51%7.76B
31.31%8.23B
47.10%7.91B
13.65%7.25B
4.13%6.83B
-16.89%6.27B
-33.79%5.38B
-15.03%6.38B
-14.85%6.56B
-12.41%7.54B
-5.49%8.13B
-21.08%7.51B
-21.57%7.71B
-16.06%8.61B
-23.53%8.60B
-16.87%9.52B
-13.11%9.83B
-6.51%10.26B
1.65%11.24B
8.11%11.45B
Cash Flow Statement
Net operating income
81.06%411.00M
61.90%-40.00M
101.39%1.16B
-46.75%369.00M
118.27%227.00M
16.00%-105.00M
-51.44%575.00M
13760.00%693.00M
-67.90%104.00M
13.79%-125.00M
21.69%1.18B
-99.08%5.00M
165.57%324.00M
-195.92%-145.00M
113.38%973.00M
2.84%544.00M
-44.04%122.00M
87.90%-49.00M
37.76%456.00M
72.31%529.00M
Net investment
-308.05%-491.00M
13.93%229.00M
-18.32%165.00M
-49.63%135.00M
32.58%236.00M
39.58%201.00M
-32.89%202.00M
45.65%268.00M
-41.06%178.00M
-20.44%144.00M
79.17%301.00M
25.17%184.00M
67.78%302.00M
12.42%181.00M
-31.71%168.00M
-48.96%147.00M
-62.58%180.00M
-68.31%161.00M
74.47%246.00M
83.44%288.00M
Net financing
-116.67%-1.00M
100.75%13.00M
105.93%40.00M
---453.00M
100.62%6.00M
-1054.97%-1.74B
-17.01%-674.00M
100.00%0.00
-1656.36%-966.00M
78.61%-151.00M
18.99%-576.00M
-30.91%-576.00M
83.73%-55.00M
-35400.00%-706.00M
-41.92%-711.00M
62.62%-440.00M
-33700.00%-338.00M
100.41%2.00M
-300.80%-501.00M
-11.35%-1.18B

FAQs

What is the total revenue of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its total revenue reached 17.32B, with a year-on-year change of 16.51B.

What are the current assets of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its current assets were 13.95B, with a year-on-year change of 11.11.

What are the total assets of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its total assets of Teva Pharmaceutical Industries Ltd were 40.75B, with a year-on-year change of 3.62.

What are the total liabilities of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its total liabilities of Teva Pharmaceutical Industries Ltd were 32.83B, with a year-on-year change of -3.28.

What is the total equity of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its total equity of Teva Pharmaceutical Industries Ltd was 7.91B, with a year-on-year change of 47.10.

What is the net operating income of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its net operating income of Teva Pharmaceutical Industries Ltd was 4.20B, with a year-on-year change of 17.87.

What is the net investment of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its net investment of Teva Pharmaceutical Industries Ltd was 737.00M, with a year-on-year change of -6.94.

What is the net financing of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its net financing of Teva Pharmaceutical Industries Ltd was -2.15B, with a year-on-year change of -20.10.

What is the Earnings Per Share (EPS) of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was 1.23, with a year-on-year change of 184.98.

What is the net income of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its net income was 1.41B, with a year-on-year change of 186.03.

What is the net margin of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its net profit margin was 8.19, with a year-on-year change of 168.99.

What is the gross margin of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its gross margin was 53.00, with a year-on-year change of 6.02.

What is the debt-to-asset ratio of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its debt-to-asset ratio was 41.25, with a year-on-year change of -8.79.

What is the Return on Equity (ROE) of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its Return on Equity (ROE) was 21.23, with a year-on-year change of 183.41.

What is the Return on Assets (ROA) of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its Return on Assets (ROA) was 3.54, with a year-on-year change of 174.85.

What is the operating profit of Teva Pharmaceutical Industries Ltd?

According to Teva Pharmaceutical Industries Ltd's FY2025 earnings report, its operating profit was 4.20B, with a year-on-year change of 17.87.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy